MARKA, the Istanbul-listed investment holding company, enters the last day of April in an interesting position — a stock up sharply over the month but quietly losing ground on the week, underpinned by a pattern of steady insider accumulation at the board level.
The most distinctive feature of MARKA's recent story is the buying by US Girişim Danışmanlık, a board-represented legal entity that has been adding shares in two tranches since the new year. In January it acquired roughly 139,000 shares at TRY 37.00, and followed with a further 12,900 shares in early February at TRY 33.88. Together those two purchases represent a 90-day net buy of over 152,000 shares, worth approximately $134,000 equivalent. The current price of TRY 53.35 is more than 50% above the February acquisition cost — a meaningful appreciation for the accumulating party, and a signal that the insider was adding into what now looks like an early-cycle low.
The price action itself tells a split story. MARKA has gained nearly 13% in the past month, recovering ground that had been lost through the early-year sell-off. But the very short-term momentum has faded: the stock dipped 1.5% over the past week and barely moved on Wednesday, adding just 0.19%. No short interest data is available for this name — it is a micro-cap holding company listed in Istanbul with a market cap of roughly $24.7 million — so the positioning picture is defined by ownership and price alone rather than lending market signals.
The broader market context is mixed. On factor scores, MARKA scores only 28 out of 100 on dividends — consistent with a corporate history that shows no cash payment since a token TRY 0.009 per share in 2012. The sector score sits at an unremarkable 50. There are no analyst ratings on record and no upcoming earnings event in the calendar. Valuation data is sparse; the most recent enterprise value figure, from December 2025, placed EV at roughly TRY 779 billion — but with the lira context and stale dating, that figure carries limited current utility.
The earnings reaction history is worth noting. At the March 2026 announcement, the stock jumped 20.9% in a single session — by far the largest reaction across recent events — though it then gave back much of that gain over the following five days, finishing that week just 5.6% ahead. Earlier prints in late 2025 produced smaller but negative one-day moves of between 3.7% and 3.8%, suggesting the stock has historically been sensitive to results in both directions. With no next earnings date yet confirmed, the timing of the next catalyst is unclear.
The setup heading into May is therefore relatively clean: insider buying at lower prices, a recovering share price, and low structural noise given the absence of short interest or analyst activity. What to watch is whether the board-level accumulation resumes — any further disclosed purchases at current prices would reinforce the picture of conviction from those closest to the company.
See the live data behind this article on ORTEX.
Open MARKA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
